mchp-20240630P3Y8180000827054March 312025Q1FALSExbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puremchp:daymchp:reportingUnit00008270542024-04-012024-06-3000008270542024-07-2600008270542024-06-3000008270542024-03-3100008270542023-04-012023-06-3000008270542023-03-3100008270542023-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-310000827054us-gaap:TreasuryStockCommonMember2023-03-310000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000827054us-gaap:RetainedEarningsMember2023-03-310000827054us-gaap:RetainedEarningsMember2023-04-012023-06-300000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-04-012023-06-300000827054us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-300000827054us-gaap:TreasuryStockCommonMember2023-06-300000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000827054us-gaap:RetainedEarningsMember2023-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-03-310000827054us-gaap:TreasuryStockCommonMember2024-03-310000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000827054us-gaap:RetainedEarningsMember2024-03-310000827054us-gaap:RetainedEarningsMember2024-04-012024-06-300000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-04-012024-06-300000827054us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000827054us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300000827054us-gaap:TreasuryStockCommonMember2024-06-300000827054us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000827054us-gaap:RetainedEarningsMember2024-06-300000827054mchp:SemiconductorProductsMember2024-04-012024-06-300000827054mchp:TechnologyLicensingMember2024-04-012024-06-300000827054mchp:SemiconductorProductsMember2023-04-012023-06-300000827054mchp:TechnologyLicensingMember2023-04-012023-06-300000827054mchp:MixedSignalMicrocontrollersMember2024-04-012024-06-300000827054mchp:MixedSignalMicrocontrollersMember2023-04-012023-06-300000827054mchp:AnalogMember2024-04-012024-06-300000827054mchp:AnalogMember2023-04-012023-06-300000827054mchp:OtherProductLineMember2024-04-012024-06-300000827054mchp:OtherProductLineMember2023-04-012023-06-300000827054us-gaap:SalesChannelThroughIntermediaryMember2024-04-012024-06-300000827054us-gaap:SalesChannelThroughIntermediaryMember2023-04-012023-06-300000827054us-gaap:SalesChannelDirectlyToConsumerMember2024-04-012024-06-300000827054us-gaap:SalesChannelDirectlyToConsumerMember2023-04-012023-06-300000827054mchp:TechnologyLicensesMember2024-04-012024-06-300000827054mchp:TechnologyLicensesMember2023-04-012023-06-300000827054mchp:SemiconductorProductsMember2024-06-300000827054us-gaap:AccruedLiabilitiesMembermchp:SemiconductorProductsMember2024-06-300000827054us-gaap:OtherNoncurrentLiabilitiesMembermchp:SemiconductorProductsMember2024-06-300000827054mchp:SemiconductorProductsMember2024-03-310000827054us-gaap:AccruedLiabilitiesMembermchp:SemiconductorProductsMember2024-03-310000827054us-gaap:OtherNoncurrentLiabilitiesMembermchp:SemiconductorProductsMember2024-03-310000827054mchp:LongTermSupplyArrangementMembermchp:SemiconductorProductsMember2024-06-300000827054us-gaap:AccruedLiabilitiesMembermchp:LongTermSupplyArrangementMembermchp:SemiconductorProductsMember2024-06-300000827054us-gaap:OtherNoncurrentLiabilitiesMembermchp:LongTermSupplyArrangementMembermchp:SemiconductorProductsMember2024-06-300000827054mchp:LongTermSupplyArrangementMembersrt:MinimumMembermchp:SemiconductorProductsMember2024-04-012024-06-300000827054srt:MaximumMembermchp:LongTermSupplyArrangementMembermchp:SemiconductorProductsMember2024-04-012024-06-3000008270542024-07-01mchp:LongTermSupplyArrangementMembermchp:SemiconductorProductsMember2024-06-300000827054mchp:SemiconductorProductsMembermchp:OtherArrangementMember2024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMember2023-04-012023-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMember2023-04-012023-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMembersrt:WeightedAverageMember2024-04-012024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMembersrt:WeightedAverageMember2023-04-012023-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMembersrt:WeightedAverageMember2024-04-012024-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMembersrt:WeightedAverageMember2023-04-012023-06-300000827054srt:WeightedAverageMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054srt:WeightedAverageMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2023-04-012023-06-300000827054srt:WeightedAverageMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054srt:WeightedAverageMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2023-04-012023-06-300000827054srt:WeightedAverageMembermchp:A2017JuniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054srt:WeightedAverageMembermchp:A2017JuniorSubordinatedConvertibleDebtMember2023-04-012023-06-300000827054mchp:TermLoanFacilityMember2024-06-300000827054mchp:TermLoanFacilityMember2024-03-310000827054us-gaap:CommercialPaperMember2024-06-300000827054us-gaap:CommercialPaperMember2024-03-310000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:SeniorNotesMember2024-03-310000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:SeniorNotesMember2024-03-310000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:SeniorNotesMember2024-03-310000827054mchp:SeniorIndebtednessMember2024-06-300000827054mchp:SeniorIndebtednessMember2024-03-310000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-03-310000827054mchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-03-310000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:ConvertibleDebtMember2024-06-300000827054us-gaap:ConvertibleDebtMember2024-03-310000827054us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2024-04-012024-06-300000827054us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2024-04-012024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-04-012024-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-04-012024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-04-012024-06-300000827054us-gaap:ConvertibleDebtMember2024-04-012024-06-300000827054mchp:SeniorIndebtednessMember2024-04-012024-06-300000827054mchp:SeniorIndebtednessMember2023-04-012023-06-300000827054us-gaap:ConvertibleDebtMember2023-04-012023-06-300000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-05-310000827054us-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-05-312024-05-310000827054us-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:TermLoanFacilityMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMembermchp:TermLoanFacilityMember2024-06-300000827054us-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:TermLoanFacilityMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMembermchp:TermLoanFacilityMember2024-03-310000827054us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommercialPaperMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialPaperMember2024-06-300000827054us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommercialPaperMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommercialPaperMember2024-03-310000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054mchp:SeniorUnsecuredNotes09832024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054mchp:SeniorUnsecuredNotes2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-06-300000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054mchp:SeniorUnsecuredNotes2029Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2024-03-310000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMember2024-06-300000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054mchp:A2015SeniorSubordinatedConvertibleDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMember2024-03-310000827054mchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMembermchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-06-300000827054mchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMembermchp:A2017SeniorSubordinatedConvertibleDebtMemberus-gaap:ConvertibleSubordinatedDebtMember2024-03-310000827054us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMembermchp:A2020SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-06-300000827054us-gaap:ConvertibleSubordinatedDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:ConvertibleSubordinatedDebtMembermchp:A2024SeniorSubordinatedConvertibleDebtMember2024-03-310000827054us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-06-300000827054us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-06-300000827054us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000827054us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000827054us-gaap:DevelopedTechnologyRightsMember2024-06-300000827054us-gaap:CustomerRelatedIntangibleAssetsMember2024-06-300000827054us-gaap:InProcessResearchAndDevelopmentMember2024-06-300000827054us-gaap:LicensingAgreementsMember2024-06-300000827054us-gaap:DevelopedTechnologyRightsMember2024-03-310000827054us-gaap:CustomerRelatedIntangibleAssetsMember2024-03-310000827054us-gaap:LicensingAgreementsMember2024-03-310000827054us-gaap:InProcessResearchAndDevelopmentMember2024-04-012024-06-300000827054us-gaap:CustomerRelatedIntangibleAssetsMember2024-04-012024-06-300000827054us-gaap:LicensingAgreementsMember2024-04-012024-06-300000827054srt:MinimumMember2024-06-300000827054srt:MaximumMember2024-06-300000827054us-gaap:CostOfSalesMember2024-04-012024-06-300000827054us-gaap:CostOfSalesMember2023-04-012023-06-300000827054us-gaap:OperatingExpenseMember2024-04-012024-06-300000827054us-gaap:OperatingExpenseMember2023-04-012023-06-300000827054mchp:SemiconductorProductsMember2024-03-310000827054mchp:TechnologyLicensingMember2024-03-310000827054mchp:SemiconductorProductsMember2024-04-012024-06-300000827054mchp:TechnologyLicensingMember2024-04-012024-06-300000827054mchp:SemiconductorProductsMember2024-06-300000827054mchp:TechnologyLicensingMember2024-06-300000827054us-gaap:TradeAccountsReceivableMember2024-06-300000827054us-gaap:TradeAccountsReceivableMember2024-03-310000827054mchp:OtherReceivablesMember2024-06-300000827054mchp:OtherReceivablesMember2024-03-310000827054us-gaap:TradeAccountsReceivableMember2023-04-012023-06-300000827054us-gaap:LandMember2024-06-300000827054us-gaap:LandMember2024-03-310000827054us-gaap:BuildingAndBuildingImprovementsMember2024-06-300000827054us-gaap:BuildingAndBuildingImprovementsMember2024-03-310000827054us-gaap:MachineryAndEquipmentMember2024-06-300000827054us-gaap:MachineryAndEquipmentMember2024-03-310000827054us-gaap:ConstructionInProgressMember2024-06-300000827054us-gaap:ConstructionInProgressMember2024-03-310000827054us-gaap:IndemnificationGuaranteeMember2024-06-300000827054mchp:MalaysianIRBMemberus-gaap:ForeignCountryMember2023-05-252023-05-250000827054us-gaap:ResearchAndDevelopmentExpenseMember2024-04-012024-06-300000827054us-gaap:ResearchAndDevelopmentExpenseMember2023-04-012023-06-300000827054us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-04-012024-06-300000827054us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300000827054us-gaap:InventoriesMember2024-04-012024-06-300000827054us-gaap:InventoriesMember2023-04-012023-06-3000008270542021-11-300000827054us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000827054us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000827054us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-04-012024-06-300000827054us-gaap:AccumulatedTranslationAdjustmentMember2024-04-012024-06-300000827054us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300000827054us-gaap:AccumulatedTranslationAdjustmentMember2024-06-3000008270542024-06-052024-06-050000827054us-gaap:SubsequentEventMember2024-08-012024-08-010000827054srt:ScenarioForecastMember2024-09-052024-09-050000827054mchp:JEricBjornholtMember2024-04-012024-06-300000827054mchp:JEricBjornholtMember2024-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2024
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from __________ to __________
Commission File Number: 0-21184
MICROCHIP TECHNOLOGY INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
| | | | | | | | |
Delaware | | 86-0629024 |
(State or Other Jurisdiction of Incorporation or Organization) | | (IRS Employer Identification No.) |
2355 W. Chandler Blvd., Chandler, AZ 85224-6199
(Address of Registrant's Principal Executive Offices)
(480) 792-7200
(Registrant's Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
Common Stock, $0.001 par value | MCHP | NASDAQ Stock Market LLC |
| | (Nasdaq Global Select Market) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:
| | | | | | | | | | | | | | | | | | | |
Large accelerated filer | ☒ | | | | | Accelerated filer | ☐ | | |
Non-accelerated filer | ☐ | | | | | Smaller reporting company | ☐ | | |
| | | | | | Emerging growth company | ☐ | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
The number of shares outstanding of the registrant's Common Stock, $0.001 par value, as of July 26, 2024 was 536,505,077.
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
INDEX
| | | | | | | | |
| | |
| | |
PART I. FINANCIAL INFORMATION |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
PART II. OTHER INFORMATION |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
Defined Terms(1)
| | | | | | | | |
Term | | Definition |
| | |
4.333% 2023 Notes | | 2023 Senior Unsecured Notes, matured on June 1, 2023 |
2.670% 2023 Notes | | 2023 Senior Unsecured Notes, matured on September 1, 2023 |
0.972% 2024 Notes | | 2024 Senior Unsecured Notes, matured on February 15, 2024 |
0.983% 2024 Notes | | 2024 Senior Unsecured Notes, maturing on September 1, 2024 |
4.250% 2025 Notes | | 2025 Senior Unsecured Notes, maturing on September 1, 2025 |
5.050% 2029 Notes | | 2029 Senior Unsecured Notes, maturing on March 15, 2029 |
2015 Senior Convertible Debt | | 2015 Senior Convertible Debt, maturing on February 15, 2025 |
2017 Senior Convertible Debt | | 2017 Senior Convertible Debt, maturing on February 15, 2027 |
2020 Senior Convertible Debt | | 2020 Senior Convertible Debt, maturing on November 15, 2024 |
2024 Senior Convertible Debt | | 2024 Senior Convertible Debt, maturing on June 1, 2030 |
2017 Junior Convertible Debt | | 2017 Junior Convertible Debt which was fully settled in May 2023 |
2025 Term Loan Facility | | $750.0 million term loan facility created pursuant to the amended Credit Agreement |
ASU | | Accounting Standards Update |
| | |
| | |
CEMs | | Client engagement managers |
CHIPS Act | | CHIPS and Science Act of 2022 |
Commercial Paper | | Short-term unsecured promissory notes, of up to $2.75 billion outstanding at any one time |
Convertible Debt | | 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, 2020 Senior Convertible Debt, 2024 Senior Convertible Debt, and 2017 Junior Convertible Debt prior to the May 2023 settlement |
Credit Agreement | | Amended and Restated Credit Agreement, dated as of December 16, 2021, among the Company, as borrower, the lenders from time to time party thereto, and J.P. Morgan Chase Bank, N.A., as administrative agent, as amended by the First Incremental Term Loan Amendment, dated as of August 31, 2023 |
| | |
EAR | | Export Administration Regulation |
| | |
| | |
| | |
| | |
ESEs | | Embedded solutions engineers |
ESG | | Environmental, social and governance |
| | |
Exchange Act | | Securities Exchange Act of 1934, as amended |
FASB | | Financial Accounting Standards Board |
FPGA | | Field-programmable gate array |
| | |
LTSAs | | Long-term supply agreements |
OEMs | | Original equipment manufacturers |
| | |
| | |
R&D | | Research and development |
Revolving Credit Facility | | $2.75 billion revolving credit facility created pursuant to the Credit Agreement |
| | |
| | |
| | |
| | |
RSUs | | Restricted stock units |
| | |
SEC | | U.S. Securities and Exchange Commission |
Senior Credit Facilities | | Revolving Credit Facility and 2025 Term Loan Facility |
Senior Indebtedness | | Revolving Credit Facility, 2025 Term Loan Facility, Commercial Paper, 4.333% 2023 Notes, 2.670% 2023 Notes, 0.972% 2024 Notes, 0.983% 2024 Notes, 4.250% 2025 Notes, and 5.050% 2029 Notes |
Senior Notes | | 2.670% 2023 Notes, 0.972% 2024 Notes, 0.983% 2024 Notes, 4.250% 2025 Notes, and 5.050% 2029 Notes |
| | |
SiC | | Silicon Carbide |
| | |
SOFR | | Secured Overnight Financing Rate |
| | |
| | |
| | |
| | |
U.S. GAAP | | U.S. Generally Accepted Accounting Principles |
(1) Certain terms used within this Form 10-Q are defined in the above table.
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share amounts; unaudited)
| | | | | | | | | | | |
ASSETS |
| June 30, | | March 31, |
| 2024 | | 2024 |
Cash and cash equivalents | $ | 315.1 | | | $ | 319.7 | |
| | | |
Accounts receivable, net | 1,095.8 | | | 1,143.7 | |
Inventories | 1,308.0 | | | 1,316.0 | |
Other current assets | 229.4 | | | 233.6 | |
Total current assets | 2,948.3 | | | 3,013.0 | |
Property, plant and equipment, net | 1,196.2 | | | 1,194.6 | |
| | | |
Goodwill | 6,681.9 | | | 6,675.4 | |
Intangible assets, net | 2,775.5 | | | 2,781.8 | |
Long-term deferred tax assets | 1,600.5 | | | 1,596.5 | |
Other assets | 637.3 | | | 611.9 | |
Total assets | $ | 15,839.7 | | | $ | 15,873.2 | |
LIABILITIES AND STOCKHOLDERS' EQUITY |
Accounts payable | $ | 196.4 | | | $ | 213.0 | |
Accrued liabilities | 1,323.9 | | | 1,307.0 | |
Current portion of long-term debt | — | | | 999.4 | |
Total current liabilities | 1,520.3 | | | 2,519.4 | |
Long-term debt | 6,167.9 | | | 5,000.4 | |
Long-term income tax payable | 655.6 | | | 649.2 | |
Long-term deferred tax liability | 32.2 | | | 28.8 | |
Other long-term liabilities | 1,057.7 | | | 1,017.6 | |
Stockholders' equity: | | | |
Preferred stock, $0.001 par value; authorized 5,000,000 shares; no shares issued or outstanding | — | | | — | |
Common stock, $0.001 par value; authorized 900,000,000 shares; 577,806,728 shares issued and 536,505,077 shares outstanding at June 30, 2024; 577,806,659 shares issued and 536,663,691 shares outstanding at March 31, 2024 | 0.5 | | | 0.5 | |
Additional paid-in capital | 2,404.3 | | | 2,482.9 | |
Common stock held in treasury: 41,301,651 shares at June 30, 2024; 41,142,968 shares at March 31, 2024 | (2,641.3) | | | (2,581.6) | |
Accumulated other comprehensive loss | (3.7) | | | (3.5) | |
Retained earnings | 6,646.2 | | | 6,759.5 | |
Total stockholders' equity | 6,406.0 | | | 6,657.8 | |
Total liabilities and stockholders' equity | $ | 15,839.7 | | | $ | 15,873.2 | |
See accompanying notes to condensed consolidated financial statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in millions, except per share amounts; unaudited)
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended June 30, | | |
| | | | | | 2024 | | 2023 | | | | |
Net sales | | | | | | $ | 1,241.3 | | | $ | 2,288.6 | | | | | |
Cost of sales | | | | | | 504.4 | | | 730.2 | | | | | |
Gross profit | | | | | | 736.9 | | | 1,558.4 | | | | | |
| | | | | | | | | | | | |
Research and development | | | | | | 241.7 | | | 298.5 | | | | | |
Selling, general and administrative | | | | | | 150.5 | | | 203.6 | | | | | |
Amortization of acquired intangible assets | | | | | | 123.0 | | | 151.5 | | | | | |
Special charges and other, net | | | | | | 2.6 | | | 1.7 | | | | | |
Operating expenses | | | | | | 517.8 | | | 655.3 | | | | | |
| | | | | | | | | | | | |
Operating income | | | | | | 219.1 | | | 903.1 | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Interest income | | | | | | 2.8 | | | 1.5 | | | | | |
Interest expense | | | | | | (61.8) | | | (47.2) | | | | | |
Loss on settlement of debt | | | | | | — | | | (9.1) | | | | | |
Other income, net | | | | | | 1.7 | | | — | | | | | |
Income before income taxes | | | | | | 161.8 | | | 848.3 | | | | | |
Income tax provision | | | | | | 32.5 | | | 181.9 | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Net income | | | | | | $ | 129.3 | | | $ | 666.4 | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Basic net income per common share | | | | | | $ | 0.24 | | | $ | 1.22 | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Diluted net income per common share | | | | | | $ | 0.24 | | | $ | 1.21 | | | | | |
Dividends declared per common share | | | | | | $ | 0.452 | | | $ | 0.383 | | | | | |
Basic common shares outstanding | | | | | | 536.7 | | | 545.1 | | | | | |
Diluted common shares outstanding | | | | | | 542.8 | | | 551.4 | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
See accompanying notes to condensed consolidated financial statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions; unaudited)
| | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | |
| 2024 | | 2023 | | | | | | |
Net income | $ | 129.3 | | | $ | 666.4 | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Components of other comprehensive loss: | | | | | | | | | |
| | | | | | | | | |
Actuarial losses related to defined benefit pension plans, net of tax effect | (0.2) | | | (0.3) | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Other comprehensive loss, net of tax effect | (0.2) | | | (0.3) | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Comprehensive income | $ | 129.1 | | | $ | 666.1 | | | | | | | |
See accompanying notes to condensed consolidated financial statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions; unaudited)
| | | | | | | | | | | | | |
| Three Months Ended June 30, |
| 2024 | | 2023 | | |
Cash flows from operating activities: | | | | | |
Net income | $ | 129.3 | | | $ | 666.4 | | | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 188.7 | | | 222.9 | | | |
Deferred income taxes | (8.1) | | | 23.9 | | | |
Share-based compensation expense related to equity incentive plans | 44.0 | | | 44.5 | | | |
Loss on settlement of debt | — | | | 9.1 | | | |
Amortization of debt discount | 16.6 | | | 1.7 | | | |
Amortization of debt issuance costs | 2.0 | | | 2.2 | | | |
| | | | | |
| | | | | |
Impairment of intangible assets | — | | | 0.5 | | | |
| | | | | |
| | | | | |
Other | (18.4) | | | (0.1) | | | |
Changes in operating assets and liabilities, excluding impact of acquisitions: | | | | | |
Decrease (increase) in accounts receivable | 47.9 | | | (159.7) | | | |
Decrease (increase) in inventories | 9.2 | | | (10.6) | | | |
(Decrease) increase in accounts payable and accrued liabilities | (41.2) | | | 34.9 | | | |
Change in other assets and liabilities | (20.7) | | | 50.5 | | | |
Change in income tax payable | 27.8 | | | 107.0 | | | |
| | | | | |
Net cash provided by operating activities | 377.1 | | | 993.2 | | | |
Cash flows from investing activities: | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Proceeds from sales of assets | — | | | 0.3 | | | |
Proceeds from capital-related government incentives | 0.1 | | | — | | | |
Investments in other assets | (52.7) | | | (30.1) | | | |
Capital expenditures | (72.9) | | | (111.1) | | | |
Net cash used in investing activities | (125.5) | | | (140.9) | | | |
Cash flows from financing activities: | | | | | |
Proceeds from borrowings on Revolving Credit Facility | — | | | 2,585.0 | | | |
Repayments of Revolving Credit Facility | — | | | (1,960.0) | | | |
| | | | | |
Proceeds from issuance of Commercial Paper | 3,573.4 | | | — | | | |
Repayments of Commercial Paper | (4,637.5) | | | — | | | |
| | | | | |
Repayment of senior notes | — | | | (1,000.0) | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Proceeds from issuance of convertible debt | 1,250.0 | | | — | | | |
Payments on settlement of convertible debt | — | | | (90.1) | | | |
Deferred financing costs | (15.6) | | | — | | | |
Purchase of capped call options | (105.0) | | | — | | | |
Proceeds from sale of common stock | 13.1 | | | 15.3 | | | |
Tax payments related to shares withheld for vested RSUs | (18.9) | | | (15.7) | | | |
Repurchase of common stock | (72.7) | | | (140.3) | | | |
Payment of cash dividends | (242.6) | | | (208.9) | | | |
Capital lease payments | (0.4) | | | (0.4) | | | |
Net cash used in financing activities | (256.2) | | | (815.1) | | | |
| | | | | |
Net (decrease) increase in cash and cash equivalents | (4.6) | | | 37.2 | | | |
Cash and cash equivalents, and restricted cash at beginning of period | 319.7 | | | 234.0 | | | |
Cash and cash equivalents, and restricted cash at end of period | $ | 315.1 | | | $ | 271.2 | | | |
| | | | | |
| | | | | |
|
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
See accompanying notes to condensed consolidated financial statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(in millions; unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock and Additional Paid-in-Capital | | Common Stock Held in Treasury | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Total Equity | | | | |
| Shares | | Amount | | Shares | | Amount | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Balance at March 31, 2023 | 577.8 | | | $ | 2,413.8 | | | 32.3 | | | $ | (1,660.2) | | | $ | (4.1) | | | $ | 5,764.1 | | | $ | 6,513.6 | | | | | |
| | | | | | | | | | | | | | | | | |
Net income | — | | | — | | | — | | | — | | | — | | | 666.4 | | | 666.4 | | | | | |
Other comprehensive loss | — | | | — | | | — | | | — | | | (0.3) | | | — | | | (0.3) | | | | | |
Proceeds from sales of common stock through employee equity incentive plans | 0.9 | | | 15.3 | | | — | | | — | | | — | | | — | | | 15.3 | | | | | |
RSU withholdings | (0.3) | | | (15.7) | | | — | | | — | | | — | | | — | | | (15.7) | | | | | |
Treasury stock used for new issuances | (0.6) | | | (14.7) | | | (0.6) | | | 14.7 | | | — | | | — | | | — | | | | | |
| | | | | | | | | | | | | | | | | |
Repurchase of common stock | — | | | — | | | 1.8 | | | (141.2) | | | — | | | — | | | (141.2) | | | | | |
Settlement of convertible debt | — | | | (43.3) | | | — | | | — | | | — | | | — | | | (43.3) | | | | | |
Share-based compensation | — | | | 45.4 | | | — | | | — | | | — | | | — | | | 45.4 | | | | | |
Cash dividend | — | | | — | | | — | | | — | | | — | | | (208.9) | | | (208.9) | | | | | |
Balance at June 30, 2023 | 577.8 | | | $ | 2,400.8 | | | 33.5 | | | $ | (1,786.7) | | | $ | (4.4) | | | $ | 6,221.6 | | | $ | 6,831.3 | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Balance at March 31, 2024 | 577.8 | | | $ | 2,483.4 | | | 41.1 | | | $ | (2,581.6) | | | $ | (3.5) | | | $ | 6,759.5 | | | $ | 6,657.8 | | | | | |
| | | | | | | | | | | | | | | | | |
Net income | — | | | — | | | — | | | — | | | — | | | 129.3 | | | 129.3 | | | | | |
Other comprehensive loss | — | | | — | | | — | | | — | | | (0.2) | | | — | | | (0.2) | | | | | |
Proceeds from sales of common stock through employee equity incentive plans | 0.8 | | | 13.1 | | | — | | | — | | | — | | | — | | | 13.1 | | | | | |
RSU withholdings | (0.2) | | | (18.9) | | | — | | | — | | | — | | | — | | | (18.9) | | | | | |
Treasury stock used for new issuances | (0.6) | | | (13.0) | | | (0.6) | | | 13.0 | | | — | | | — | | | — | | | | | |
Repurchase of common stock | — | | | — | | | 0.8 | | | (72.7) | | | — | | | — | | | (72.7) | | | | | |
Purchase of capped call options | — | | | (105.0) | | | — | | | — | | | — | | | — | | | (105.0) | | | | | |
| | | | | | | | | | | | | | | | | |
Share-based compensation | — | | | 45.2 | | | — | | | — | | | — | | | — | | | 45.2 | | | | | |
Cash dividend | — | | | — | | | — | | | — | | | — | | | (242.6) | | | (242.6) | | | | | |
Balance at June 30, 2024 | 577.8 | | | $ | 2,404.8 | | | 41.3 | | | $ | (2,641.3) | | | $ | (3.7) | | | $ | 6,646.2 | | | $ | 6,406.0 | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
See accompanying notes to condensed consolidated financial statements
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
Note 1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements include the accounts of Microchip Technology Incorporated and its majority-owned and controlled subsidiaries (the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the interim periods reported. Certain information and footnote disclosures normally included in audited consolidated financial statements have been condensed or omitted pursuant to such SEC rules and regulations. It is suggested that these condensed consolidated financial statements be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2024. The results of operations for the three months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2025 or for any other period.
Note 2. Recently Issued Accounting Pronouncements and Other Developments
Recently Issued Accounting Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07-Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, and an amount and description of the composition of other segment items to reconcile to segment profit or loss. The amendments in this update also expand the interim segment disclosure requirements. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted with retrospective application required for all prior periods presented in the financial statements. The Company is currently evaluating the applicable disclosures.
In December 2023, the FASB issued ASU 2023-09-Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to enhance the transparency and decision-usefulness of income tax disclosures, particularly in the rate reconciliation table and disclosures about income taxes paid. The amendments are intended to address investors’ requests for income tax disclosures that provide more information to help them better understand an entity’s exposure to potential changes in tax laws and the ensuing risks and opportunities and to assess income tax information that affects cash flow forecasts and capital allocation decisions. The guidance also eliminates certain existing disclosure requirements related to uncertain tax positions and unrecognized deferred tax liabilities. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 with early adoption permitted. All entities should apply the guidance prospectively but have the option to apply it retrospectively. The Company is continuing to assess the timing of adoption and the potential impacts of ASU 2023-09.
SEC Climate Disclosures
In March 2024, the SEC issued final rules requiring registrants to include comprehensive climate-related disclosures in annual reports and registration statements. As adopted, the final rules require large accelerated filers to make their first climate-related disclosures for fiscal years beginning in 2025. However, in April 2024, the SEC issued an order voluntarily staying the effectiveness of the new rules pending the completion of judicial review of certain legal challenges to their validity. The Company is currently evaluating these rules as adopted as well as monitoring the status of the related litigation and the SEC’s stay.
Note 3. Segment Information
The Company's reportable segments are semiconductor products and technology licensing. The Company does not allocate operating expenses, interest income, interest expense, other income or expense, or provision for or benefit from income taxes to these segments for internal reporting purposes, as the Company does not believe that allocating these expenses is beneficial in evaluating segment performance. Additionally, the Company does not allocate assets to segments for internal reporting purposes as it does not manage its segments by such metrics.
The following tables represent net sales and gross profit for each segment for the periods presented (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | |
| | | | | | | Three Months Ended June 30, 2024 | | |
| | | | | | | | | | | | | Net Sales | | Gross Profit | | | | |
Semiconductor products | | | | | | | | | | | | | $ | 1,219.1 | | | $ | 714.7 | | | | | |
Technology licensing | | | | | | | | | | | | | 22.2 | | | 22.2 | | | | | |
Total | | | | | | | | | | | | | $ | 1,241.3 | | | $ | 736.9 | | | | | |
| | | | | | | | | | | | | | | |
| | | |
| Three Months Ended June 30, 2023 | | |
| Net Sales | | Gross Profit | | | | |
Semiconductor products | $ | 2,254.8 | | | $ | 1,524.6 | | | | | |
Technology licensing | 33.8 | | | 33.8 | | | | | |
Total | $ | 2,288.6 | | | $ | 1,558.4 | | | | | |
Note 4. Net Sales
The following table represents the Company's net sales by product line (in millions):
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Mixed-signal Microcontrollers | | | | | | | $ | 644.7 | | | $ | 1,301.7 | | | | | |
Analog | | | | | | | 330.6 | | | 633.6 | | | | | |
| | | | | | | | | | | | | |
Other | | | | | | | 266.0 | | | 353.3 | | | | | |
Total net sales | | | | | | | $ | 1,241.3 | | | $ | 2,288.6 | | | | | |
The product lines listed above are included entirely in the Company's semiconductor product segment with the exception of the other product line, which includes products from both the semiconductor product and technology licensing segments.
The following table represents the Company's net sales by customer type (in millions):
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Distributors | | | | | | | $ | 584.4 | | | $ | 1,107.9 | | | | | |
Direct customers | | | | | | | 634.7 | | | 1,146.9 | | | | | |
Licensees | | | | | | | 22.2 | | | 33.8 | | | | | |
Total net sales | | | | | | | $ | 1,241.3 | | | $ | 2,288.6 | | | | | |
Distributors are customers that buy products with the intention of reselling them. Distributors generally have a distributor agreement with the Company to govern the terms of the relationship. Direct customers are non-distributor customers, which generally do not have a master sales agreement with the Company. The Company's direct customers primarily consist of OEMs and, to a lesser extent, contract manufacturers. Licensees are customers of the Company's technology licensing segment, which include purchasers of intellectual property and customers that have licensing agreements to use the Company's SuperFlash® embedded flash technology. All of the customer types listed in the table above are included in the Company's semiconductor product segment with the exception of licensees, which is included in the technology licensing segment. All of the Company's net sales are recognized from contracts with customers.
The consideration received from customers is fixed, with the exception of consideration from certain distributors and customers under LTSAs. Certain of the Company's distributors are granted price concessions and return rights, which result in
variable consideration. The amount of revenue recognized for sales to these certain distributors is adjusted for estimates of the price concessions and return rights that are expected to be claimed. These estimates are based on the recent history of price concessions and stock rotations, which are recorded as refund liabilities within accrued liabilities on the Company's condensed consolidated balance sheets.
The Company collects amounts in advance for certain of its contracts with customers. These amounts are deferred until control of the product or service is transferred to the customer at which time it is recognized as revenue. As of June 30, 2024, the Company had approximately $914.5 million of deferred revenue, of which $262.6 million is included within accrued liabilities and the remaining $651.9 million is included within other long-term liabilities on the Company's condensed consolidated balance sheet. As of March 31, 2024, the Company had approximately $933.0 million of deferred revenue, of which $261.8 million is included within accrued liabilities and the remaining $671.2 million is included within other long-term liabilities on the Company's condensed consolidated balance sheets. Deferred revenue represents amounts that have been invoiced in advance which are expected to be recognized as revenue in future periods. Approximately $73.8 million of deferred revenue recorded on the Company's consolidated balance sheets as of March 31, 2024, was recognized as revenue during the three months ended June 30, 2024. Approximately $52.6 million of deferred revenue recorded on the Company's consolidated balance sheets as of March 31, 2023, was recognized as revenue during the three months ended June 30, 2023.
Of the $914.5 million of deferred revenue as of June 30, 2024, $822.4 million is cash collected from customers under LTSAs, of which $179.8 million is included within accrued liabilities and $642.6 million is included within other long-term liabilities. Under these LTSAs, the Company receives an upfront deposit from the customer in exchange for assured supply over the contract period, which typically ranges from three to five years. If the customer does not meet the minimum purchase commitments defined in the contract, the Company may retain all, or portions of, the deposit as revenue. If the Company fails to assure supply as defined in the contract, the deposit, or portions of it, will be returned to the customer. The transaction price for the remaining performance obligations for the LTSAs were approximately $3.30 billion as of June 30, 2024, of which approximately 25% is expected to be recognized as net sales during the next 12 months. The amount and timing of such net sales is uncertain because it depends on the satisfaction of commitments made in the LTSAs, which may be affected by the timing and amount of orders placed by customers, contract modifications, variable consideration, sales channels, and manufacturing and supply chain conditions. Accordingly, the amount may not be indicative of net sales in future periods. The remaining $92.1 million of deferred revenue as of June 30, 2024 is related to other cash payments received from customers in advance of the Company’s performance obligations being satisfied. Most of the $92.1 million will be recognized as net sales within the next 12 months. The amount of other firmly committed orders with performance obligations in excess of 12 months at the time of order is immaterial.
Note 5. Net Income Per Common Share
The following table sets forth the computation of basic and diluted net income per common share (in millions, except per share amounts):
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Net income | | | | | | | $ | 129.3 | | | $ | 666.4 | | | | | |
Basic weighted average common shares outstanding | | | | | | | 536.7 | | | 545.1 | | | | | |
Dilutive effect of RSUs | | | | | | | 5.2 | | | 5.1 | | | | | |
| | | | | | | | | | | | | |
Dilutive effect of 2015 Senior Convertible Debt | | | | | | | 0.2 | | | 0.3 | | | | | |
Dilutive effect of 2017 Senior Convertible Debt | | | | | | | 0.7 | | | 0.9 | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Diluted weighted average common shares outstanding | | | | | | | 542.8 | | | 551.4 | | | | | |
Basic net income per common share | | | | | | | $ | 0.24 | | | $ | 1.22 | | | | | |
Diluted net income per common share | | | | | | | $ | 0.24 | | | $ | 1.21 | | | | | |
The Company computed basic net income per common share based on the weighted average number of common shares outstanding during the period. The Company computed diluted net income per common share based on the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period.
Potentially dilutive common shares from employee equity incentive plans are determined by applying the treasury stock method to the assumed vesting of outstanding RSUs. Prior to conversion of its Convertible Debt, the Company will include, in the diluted net income per common share calculation, the effect of the additional shares that may be issued when the Company's common stock price exceeds the conversion price using the if-converted method. The Company's Convertible Debt has no impact on diluted net income per common share unless the average price of the Company's common stock
exceeds the conversion price because the Company is required to settle the principal amount of the Convertible Debt in cash upon conversion.
The following is the weighted average conversion price per share used in calculating the dilutive effect (see Note 6 for details on the Convertible Debt):
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
| | | | | | | | | | | | | |
2015 Senior Convertible Debt | | | | | | | $ | 28.66 | | | $ | 29.25 | | | | | |
2017 Senior Convertible Debt | | | | | | | $ | 44.69 | | | $ | 45.61 | | | | | |
2020 Senior Convertible Debt | | | | | | | $ | 91.23 | | | $ | 92.32 | | | | | |
2024 Senior Convertible Debt | | | | | | | $ | 121.84 | | | $ | — | | | | | |
2017 Junior Convertible Debt(1) | | | | | | | $ | — | | | $ | 44.81 | | | | | |
(1) The weighted average conversion price per share for the 2017 Junior Convertible Debt was prior to the settlement of the outstanding principal amount in May 2023.
Note 6. Debt
Debt obligations included in the condensed consolidated balance sheets consisted of the following (in millions)(1):
| | | | | | | | | | | | | | | | | | | | | | | | |
| Coupon Interest Rate | | Effective Interest Rate | | | | | |
| | | June 30, | | March 31, |
| | | 2024 | | 2024 |
| | | | | | | | |
2025 Term Loan Facility | | | | | | $ | 750.0 | | | $ | 750.0 | |
Commercial Paper | | | | | | 288.0 | | | 1,359.0 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
0.983% 2024 Notes | 0.983% | | 1.1% | | | 1,000.0 | | | 1,000.0 | |
4.250% 2025 Notes | 4.250% | | 4.6% | | | 1,200.0 | | | 1,200.0 | |
5.050% 2029 Notes | 5.050% | | 5.2% | | | 1,000.0 | | | 1,000.0 | |
Total Senior Indebtedness | | | | | | 4,238.0 | | | 5,309.0 | |
Senior Subordinated Convertible Debt - Principal Outstanding | | | |
2015 Senior Convertible Debt | 1.625% | | 1.8% | | | 6.7 | | | 6.7 | |
2017 Senior Convertible Debt | 1.625% | | 1.8% | | | 38.0 | | | 38.0 | |
2020 Senior Convertible Debt | 0.125% | | 0.5% | | | 665.5 | | | 665.5 | |
| | | |
| | | | | | | | |
| | | | | | | | |
2024 Senior Convertible Debt | 0.750% | | 1.2% | | | 1,250.0 | | | — | |
Total Convertible Debt | | | | | | 1,960.2 | | | 710.2 | |
| | | | | | | | |
Gross long-term debt including current maturities | | | | | | 6,198.2 | | | 6,019.2 | |
Less: Debt discount(2) | | | | | | (9.9) | | | (13.9) | |
Less: Debt issuance costs(3) | | | | | | (20.4) | | | (5.5) | |
Net long-term debt including current maturities | | | | | | 6,167.9 | | | 5,999.8 | |
Less: Current maturities(4) | | | | | | — | | | (999.4) | |
Net long-term debt | | | | | | $ | 6,167.9 | | | $ | 5,000.4 | |
(1) The Company had no outstanding borrowings under the Revolving Credit Facility at June 30, 2024 and at March 31, 2024.
(2) The unamortized discount consists of the following (in millions):
| | | | | | | | | | | | | | | |
| | | | | June 30, | | March 31, |
| | | | | 2024 | | 2024 |
| | | | | | | |
| | | | | | | |
Commercial Paper | | | | | $ | (1.1) | | | $ | (3.9) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
0.983% 2024 Notes | | | | | (0.2) | | | (0.4) | |
4.250% 2025 Notes | | | | | (3.6) | | | (4.4) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
5.050% 2029 Notes | | | | | (5.0) | | | (5.2) | |
Total unamortized discount | | | | | $ | (9.9) | | | $ | (13.9) | |
(3) Debt issuance costs consist of the following (in millions):
| | | | | | | | | | | | | | | |
| June 30, | | March 31, | | | | |
| 2024 | | 2024 | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
2025 Term Loan Facility | $ | (0.5) | | | $ | (0.7) | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
0.983% 2024 Notes | (0.1) | | | (0.2) | | | | | |
4.250% 2025 Notes | (0.5) | | | (0.6) | | | | | |
| | | | | | | |
5.050% 2029 Notes | (2.1) | | | (2.2) | | | | | |
2017 Senior Convertible Debt | (0.1) | | | (0.1) | | | | | |
2020 Senior Convertible Debt | (1.0) | | | (1.7) | | | | | |
| | | | | | | |
2024 Senior Convertible Debt | (16.1) | | | — | | | | | |
Total debt issuance costs | $ | (20.4) | | | $ | (5.5) | | | | | |
(4) As of June 30, 2024, the 0.983% 2024 Notes which mature on September 1, 2024, the outstanding Commercial Paper which matures within the three months ending September 30, 2024, and the 2020 Senior Convertible Debt which matures on November 15, 2024, and will be convertible on August 15, 2024, were excluded from current maturities as the Company has the intent and ability to utilize proceeds from its Revolving Credit Facility to refinance such notes on a long-term basis. As of June 30, 2024, the 2015 Senior Convertible Debt which matures on February 15, 2025, and the 2017 Senior Convertible Debt which matures on February 15, 2027, were convertible and are excluded from current maturities as the Company has the intent and ability to utilize proceeds from its Revolving Credit Facility to settle the principal portion of its Convertible Debt upon conversion. As of March 31, 2024, current maturities consisted of the 0.983% 2024 Notes. As of March 31, 2024, the outstanding Commercial Paper which matured within the three months ended June 30, 2024 and the 2020 Senior Convertible Debt were excluded from current maturities as the Company had the intent and ability to utilize proceeds from its Revolving Credit Facility to refinance such notes on a long-term basis. As of March 31, 2024, the 2015 Senior Convertible Debt and the 2017 Senior Convertible Debt were convertible and were excluded from current maturities as the Company had the intent and ability to utilize proceeds from its Revolving Credit Facility to settle the principal portion of its Convertible Debt upon conversion.
Expected maturities relating to the Company’s debt obligations based on the contractual maturity dates as of June 30, 2024, are as follows (in millions):
| | | | | | | | |
Fiscal year ending March 31, | | Amount |
2025 | | $ | 1,960.2 | |
2026 | | 1,950.0 | |
2027 | | 38.0 | |
2028 | | — | |
2029 | | 1,000.0 | |
Thereafter | | 1,250.0 | |
Total | | $ | 6,198.2 | |
Ranking of Convertible Debt - Each series of Convertible Debt is an unsecured obligation which is subordinated in right of payment to the amounts outstanding under the Company's Senior Indebtedness. The Senior Subordinated Convertible Debt is subordinated to the Senior Indebtedness; ranks senior to the Company's indebtedness that is expressly subordinated in right of payment to it; ranks equal in right of payment to any of the Company's unsubordinated indebtedness that does not provide that it is senior to the Senior Subordinated Convertible Debt; ranks junior in right of payment to any of the Company's secured and unsecured unsubordinated indebtedness to the extent of the value of the assets securing such indebtedness; and is structurally subordinated to all indebtedness and other liabilities of the Company's subsidiaries.
Summary of Conversion Features - On April 1, 2022, the Company irrevocably elected cash settlement for the principal amount of its Convertible Debt. Each series of Convertible Debt is convertible, subject to certain conditions, into cash, shares of the Company's common stock or a combination thereof, at the Company's election, at specified conversion rates (see table below), adjusted for certain events including the declaration of cash dividends. Except during the three-month period immediately preceding the maturity date of the applicable series of Convertible Debt, each series of Convertible Debt is convertible only upon the occurrence of (i) such time as the closing price of the Company's common stock exceeds the applicable conversion price (see table below) by 130% for 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter, (ii) during the 5 business day period after any 10 consecutive trading day period, or the measurement period, in which the trading price per $1,000
principal amount of notes of a given series for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the applicable conversion rate on each such trading day, or (iii) upon the occurrence of certain corporate events specified in the indenture of such series of Convertible Debt. In addition, for each series, with the exception of the 2020 Senior Convertible Debt and the 2024 Senior Convertible Debt, if at the time of conversion the applicable price of the Company's common stock exceeds the applicable conversion price at such time, the applicable conversion rate will be increased by up to an additional maximum incremental shares rate, as determined pursuant to a formula specified in the indenture for the applicable series of Convertible Debt, and as adjusted for cash dividends paid since the issuance of such series of Convertible Debt. However, in no event will the applicable conversion rate exceed the applicable maximum conversion rate specified in the indenture for the applicable series of Convertible Debt (see table below).
The following table sets forth the applicable conversion rates adjusted for dividends declared since issuance of such series of Convertible Debt and the applicable incremental share factors and maximum conversion rates as adjusted for dividends paid since the applicable issuance date:
| | | | | | | | | | | | | | | | | | | | | | | |
| Dividend adjusted rates as of June 30, 2024 |
| Conversion Rate | | Approximate Conversion Price | | Incremental Share Factor | | Maximum Conversion Rate |
2015 Senior Convertible Debt(1) | 34.8964 | | | $ | 28.66 | | | 17.4500 | | | 48.8541 | |
2017 Senior Convertible Debt(1) | 22.3771 | | | $ | 44.69 | | | 11.1894 | | | 31.8874 | |
2020 Senior Convertible Debt(1) | 10.9615 | | | $ | 91.23 | | | — | | | 15.3461 | |
2024 Senior Convertible Debt(1) | 8.2076 | | | $ | 121.84 | | | — | | | 10.4646 | |
| | | | | | | |
| | | | | | | |
(1) As of June 30, 2024, the 2020 Senior Convertible Debt and the 2024 Senior Convertible Debt were not convertible. As of June 30, 2024, the holders of each of the 2015 Senior Convertible Debt and 2017 Senior Convertible Debt have the right to convert their notes between July 1, 2024 and September 30, 2024 because the Company's common stock price has exceeded the applicable conversion price for such series by 130% for the specified period of time during the quarter ended June 30, 2024.
With the exception of the 2020 Senior Convertible Debt, which became redeemable by the Company after November 20, 2022, and the 2024 Senior Convertible Debt, which may be redeemed by the Company on or after June 5, 2027, the Company may not redeem any series of Convertible Debt prior to the relevant maturity date and no sinking fund is provided for any series of Convertible Debt. Under the terms of the applicable indenture, the Company may repurchase any series of Convertible Debt in the open market or through privately negotiated exchange offers. Upon the occurrence of a fundamental change, as defined in the applicable indenture of such series of Convertible Debt, holders of such series may require the Company to purchase all or a portion of their Convertible Debt for cash at a price equal to 100% of the principal amount plus any accrued and unpaid interest.
Interest expense consists of the following (in millions):
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Debt issuance cost amortization | | | | | | | $ | 0.9 | | | $ | 1.5 | | | | | |
Debt discount amortization | | | | | | | 16.6 | | | 1.7 | | | | | |
Interest expense | | | | | | | 41.3 | | | 41.5 | | | | | |
Total interest expense on Senior Indebtedness | | | | | | | 58.8 | | | 44.7 | | | | | |
Debt issuance cost amortization | | | | | | | 1.1 | | | 0.7 | | | | | |
| | | | | | | | | | | | | |
Coupon interest expense | | | | | | | 1.1 | | | 0.5 | | | | | |
Total interest expense on Convertible Debt | | | | | | | 2.2 | | | 1.2 | | | | | |
Other interest expense | | | | | | | 0.8 | | | 1.3 | | | | | |
Total interest expense | | | | | | | $ | 61.8 | | | $ | 47.2 | | | | | |
Convertible Debt
In May 2024, the Company issued $1.25 billion aggregate principal amount of 2024 Senior Convertible Debt and incurred issuance costs of $16.5 million. Interest on the 2024 Senior Convertible Debt is payable semi-annually in arrears on June 1 and December 1. The 2024 Senior Convertible Debt will mature on June 1, 2030 unless redeemed, repurchased or converted.
In connection with the issuance of the 2024 Senior Convertible Debt, the Company entered into capped call option transactions with several financial institutions at a cost of $105.0 million. The capped call options cover, subject to anti-dilution adjustments, the number of shares of the Company's common stock initially underlying the 2024 Senior Convertible Debt. Upon conversion of the 2024 Senior Convertible Debt, the Company may exercise the capped call options subject to a cap price of $167.23 per share, subject to certain adjustments under the terms of the capped call options, which are generally expected to reduce the potential dilution to the Company's common stock upon conversion of the 2024 Senior Convertible Debt and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2024 Senior Convertible Debt. Upon conversion of the 2024 Senior Convertible Debt, there will be no economic dilution from the 2024 Senior Convertible Debt until the average market price of the Company's common stock exceeds the cap price of $167.23 per share as the exercise of the capped call options will offset any dilution from the 2024 Senior Convertible Debt from the conversion price up to the cap price. As these transactions meet certain accounting criteria, the capped call options are recorded as a reduction of stockholders' equity and are not accounted for as derivatives.
Commercial Paper
In September 2023, the Company established a Commercial Paper program under which the Company may issue short-term unsecured promissory notes up to a maximum principal amount outstanding at any time of $2.75 billion with a maturity of up to 397 days from the date of issue. The Company's obligations with respect to the payment of the Commercial Paper are guaranteed by certain of its subsidiaries. The Commercial Paper will be sold at a discount from par or alternatively, will be sold at par and bear interest rates that will vary based on market conditions and the time of issuance. The Company's intention is to reduce the amounts that would otherwise be available to borrow under the Company's Revolving Credit Facility by the outstanding amount of Commercial Paper. As of June 30, 2024, the Company had $288.0 million of principal amount of Commercial Paper outstanding. The weighted-average interest rate of the Company's outstanding Commercial Paper was 5.55% as of June 30, 2024.
Note 7. Fair Value of Financial Instruments
Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1-Observable inputs such as quoted prices in active markets;
Level 2-Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
Level 3-Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
The carrying amount of cash equivalents approximates fair value because their maturity is less than three months. The carrying amount of accounts receivable, accounts payable and accrued liabilities approximates fair value due to the short-term maturity of the amounts and are considered Level 2 in the fair value hierarchy.
The fair value of the Company's 2025 Term Loan Facility, and the Commercial Paper, is estimated using discounted cash flow analysis, based on the Company's current incremental borrowing rates for similar types of borrowing arrangements. Based on the borrowing rates currently available to the Company for bank loans with similar terms and average maturities, the fair value of the Company's 2025 Term Loan Facility, and the Commercial Paper at June 30, 2024 approximated the carrying value excluding debt discounts and debt issuance costs and are considered Level 2 in the fair value hierarchy. The Company measures the fair value of its Convertible Debt and Senior Notes for disclosure purposes. These fair values are based on observable market prices for this debt, which is traded in less active markets and are therefore classified as a Level 2 fair value measurement.
The following table shows the carrying amounts and fair values of the Company's debt obligations (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| June 30, 2024 | | March 31, 2024 |
| Carrying Amount(1) | | Fair Value | | Carrying Amount(1) | | Fair Value |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
2025 Term Loan Facility | $ | 749.5 | | | $ | 750.0 | | | $ | 749.3 | | | $ | 750.0 | |
Commercial Paper | 286.9 | | | 288.0 | | | 1,355.1 | | | 1,359.0 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
0.983% 2024 Notes | 999.7 | | | 991.5 | | | 999.4 | | | 979.6 | |
4.250% 2025 Notes | 1,195.9 | | | 1,181.9 | | | 1,195.0 | | | 1,181.8 | |
5.050% 2029 Notes | 992.9 | | | 993.1 | | | 992.6 | | | 1,000.6 | |
2015 Senior Convertible Debt | 6.7 | | | 25.6 | | | 6.7 | | | 25.6 | |
2017 Senior Convertible Debt | 37.9 | | | 102.4 | | | 37.9 | | | 101.3 | |
2020 Senior Convertible Debt | 664.5 | | | 700.7 | | | 663.8 | | | 708.8 | |
2024 Senior Convertible Debt | 1,233.9 | | | 1,265.3 | | | — | | | — | |
| | | | | | | |
Total | $ | 6,167.9 | | | $ | 6,298.5 | | | $ | 5,999.8 | | | $ | 6,106.7 | |
| | | | | | | |
(1) The carrying amounts presented are net of debt discounts and debt issuance costs (see Note 6 for further information).
Note 8. Intangible Assets and Goodwill
Net amounts excluding fully amortized intangible assets, consist of the following (in millions):
| | | | | | | | | | | | | | | | | | |
| | June 30, 2024 |
| | Gross Amount | | Accumulated Amortization | | Net Amount |
Core and developed technology | | $ | 7,210.6 | | | $ | (4,698.1) | | | $ | 2,512.5 | |
Customer-related | | 199.5 | | | (143.9) | | | 55.6 | |
| | | | | | |
| | | | | | |
In-process research and development | | 54.0 | | | — | | | 54.0 | |
Software licenses | | 239.5 | | | (86.1) | | | 153.4 | |
| | | | | | |
Total | | $ | 7,703.6 | | | $ | (4,928.1) | | | $ | 2,775.5 | |
| | | | | | | | | | | | | | | | | | |
| | March 31, 2024 |
| | Gross Amount | | Accumulated Amortization | | Net Amount |
Core and developed technology | | $ | 7,221.3 | | | $ | (4,590.9) | | | $ | 2,630.4 | |
Customer-related | | 196.7 | | | (140.8) | | | 55.9 | |
| | | | | | |
| | | | | | |
| | | | | | |
Software licenses | | 230.7 | | | (135.2) | | | 95.5 | |
| | | | | | |
Total | | $ | 7,648.7 | | | $ | (4,866.9) | | | $ | 2,781.8 | |
During the three months ended June 30, 2024, due to acquisitions, the Company acquired $54.0 million of in-process research and development, $2.8 million of customer-related intangible assets, and $1.1 million of software licenses intangible assets. The amounts are considered immaterial for disclosure purposes. The following is an expected amortization schedule for the intangible assets for the remainder of fiscal 2025 through fiscal 2029, absent any future acquisitions or impairment charges (in millions):
| | | | | | | | |
Fiscal Year Ending March 31, | | Amortization Expense |
2025 | | $ | 433.6 | |
2026 | | $ | 514.2 | |
2027 | | $ | 418.1 | |
2028 | | $ | 310.6 | |
2029 | | $ | 236.4 | |
The Company amortizes intangible assets over their expected useful lives, which range between 1 and 15 years. Amortization expense attributed to intangible assets are assigned to cost of sales and operating expenses as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Amortization expense charged to cost of sales | | | | | | | $ | 3.7 | | | $ | 3.0 | | | | | |
Amortization expense charged to operating expense | | | | | | | 142.0 | | | 169.4 | | | | | |
Total amortization expense | | | | | | | $ | 145.7 | | | $ | 172.4 | | | | | |
Goodwill activity by segment was as follows (in millions):
| | | | | | | | | | | |
| Semiconductor Products Reporting Unit | | Technology Licensing Reporting Unit |
| | | |
| | | |
Balance at March 31, 2024 | $ | 6,656.2 | | | $ | 19.2 | |
Immaterial additions due to acquisitions | 6.5 | | | — | |
Balance at June 30, 2024 | $ | 6,662.7 | | | $ | 19.2 | |
At March 31, 2024, the Company applied a qualitative goodwill impairment test to its two reporting units, and concluded that goodwill was not impaired. Through June 30, 2024, the Company has never recorded a goodwill impairment charge.
Note 9. Other Financial Statement Details
Accounts Receivable
Accounts receivable consists of the following (in millions):
| | | | | | | | | | | |
| June 30, | | March 31, |
| 2024 | | 2024 |
Trade accounts receivable | $ | 1,086.4 | | | $ | 1,141.7 | |
Other | 16.8 | | | 10.1 | |
Total accounts receivable, gross | 1,103.2 | | | 1,151.8 | |
Less: allowance for expected credit losses | 7.4 | | | 8.1 | |
Total accounts receivable, net | $ | 1,095.8 | | | $ | 1,143.7 | |
The Company sells certain of its trade accounts receivable on a non-recourse basis to a third-party financial institution pursuant to a factoring arrangement. The Company accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the consolidated statements of cash flows. Total trade accounts receivable sold under the factoring arrangement were $64.9 million in the three months ended June 30, 2023. The Company paused this program in the second quarter of fiscal 2024.
Inventories
The components of inventories consist of the following (in millions):
| | | | | | | | | | | |
| June 30, | | March 31, |
| 2024 | | 2024 |
Raw materials | $ | 186.3 | | | $ | 184.0 | |
Work in process | 843.9 | | | 797.5 | |
Finished goods | 277.8 | | | 334.5 | |
Total inventories | $ | 1,308.0 | | | $ | 1,316.0 | |
Property, Plant and Equipment
Property, plant and equipment consists of the following (in millions):
| | | | | | | | | | | |
| June 30, | | March 31, |
| 2024 | | 2024 |
Land | $ | 89.3 | | | $ | 89.3 | |
Building and building improvements | 802.2 | | | 796.3 | |
Machinery and equipment | 2,778.8 | | | 2,778.1 | |
Projects in process | 382.3 | | | 349.6 | |
Total property, plant and equipment, gross | 4,052.6 | | | 4,013.3 | |
Less: accumulated depreciation and amortization | 2,856.4 | | | 2,818.7 | |
Total property, plant and equipment, net | $ | 1,196.2 | | | $ | 1,194.6 | |
Depreciation expense attributed to property, plant and equipment was $43.0 million for the three months ended June 30, 2024 compared to $50.5 million for the three months ended June 30, 2023.
The Company reviews and evaluates its long-lived assets for impairment when events or changes in circumstances indicate that the related carrying amount of such assets may not be recoverable. For each of the three months ended June 30, 2024 and June 30, 2023, the Company’s evaluation of its property, plant and equipment did not result in any material impairments.
Accrued Liabilities
Accrued liabilities consists of the following (in millions):
| | | | | | | | | | | |
| June 30, | | March 31, |
| 2024 | | 2024 |
Accrued compensation and benefits | $ | 132.1 | | | $ | 117.8 | |
Income taxes payable | 110.7 | | | 90.8 | |
Deferred revenue | 262.6 | | | 261.8 | |
Sales related reserves | 516.6 | | | 580.6 | |
Current portion of lease liabilities | 35.0 | | | 32.6 | |
Accrued expenses and other liabilities | 266.9 | | | 223.4 | |
Total accrued liabilities | $ | 1,323.9 | | | $ | 1,307.0 | |
Note 10. Commitments and Contingencies
Purchase Commitments
The Company's purchase commitments primarily consist of agreements for the purchase of property, plant and equipment and other goods and services including wafer purchase obligations with the Company's wafer foundries, and manufacturing supply capacity reservation commitments.
Total purchase commitments as of June 30, 2024, are as follows (in millions):
| | | | | | | | |
Fiscal Year Ending March 31, | | Purchase Commitments |
2025 | | $ | 376.4 | |
2026 | | 221.1 | |
2027 | | 245.5 | |
2028 | | 203.0 | |
2029 | | 90.2 | |
Thereafter | | 85.8 | |
Total | | $ | 1,222.0 | |
Indemnification Contingencies
The Company's technology license agreements generally include an indemnification clause that indemnifies the licensee against liability and damages (including legal defense costs) arising from any claims of patent, copyright, trademark or trade secret infringement by the Company's proprietary technology. The terms of these indemnification provisions approximate the terms of the outgoing technology license agreements, which are typically perpetual unless terminated by either party for breach. The possible amount of future payments the Company could be required to make based on agreements that specify indemnification limits, if such indemnifications were required on all of these agreements, is approximately $189.0 million. There are some licensing agreements in place that do not specify indemnification limits. As of June 30, 2024, the Company had not recorded any liabilities related to these indemnification obligations and the Company believes that any amounts that it may be required to pay under these agreements in the future will not have a material adverse effect on its financial position, cash flows or results of operations.
Warranty Costs and Product Liabilities
The Company accrues for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, the Company has experienced a low rate of payments on product claims. Although the Company cannot predict the likelihood or amount of any future claims, the Company does not believe these claims will have a material adverse effect on its financial condition, results of operations or liquidity.
Legal Matters
In the ordinary course of the Company's business, it is exposed to various legal actions as a result of contracts, product liability, customer claims, pricing or royalty disputes with customers and licensees, governmental investigations and other matters. The Company is involved in a limited number of these legal actions, both as plaintiff and defendant, with respect to the foregoing types of matters. Consequently, the Company could incur uninsured liability in any of these legal actions. The Company also periodically receives notifications from various third parties alleging infringement of patents or other intellectual property rights, or from customers requesting reimbursement for various costs. With respect to pending legal actions to which the Company is a party and other claims, although the outcomes are generally not determinable, the Company believes that the ultimate resolution of these matters (other than certain tax matters in the U.S. and Malaysia as
described in Note 11 below) will not have a material adverse effect on its financial position, cash flows or results of operations. Litigation, governmental investigations and disputes relating to the semiconductor industry are not uncommon, and the Company is, from time to time, subject to such litigation, governmental investigations and disputes. As a result, no assurances can be given with respect to the extent or outcome of any such litigation, governmental investigations or disputes in the future.
The Company accrues for claims and contingencies when losses become probable and reasonably estimable. As of the end of each applicable reporting period, the Company reviews each of its matters and, where it is probable that a liability has been or will be incurred, the Company accrues for all probable and reasonably estimable losses. Where the Company can reasonably estimate a range of losses it may incur regarding such a matter, the Company records an accrual for the amount within the range that constitutes its best estimate. If the Company can reasonably estimate a range but no amount within the range appears to be a better estimate than any other, the Company uses the amount that is the low end of such range. As of June 30, 2024, the Company's estimate of the aggregate potential liability for legal matters that is possible but not probable is approximately $125.0 million in excess of amounts accrued.
Note 11. Income Taxes
The Company accounts for income taxes in accordance with ASC 740. The provision for income taxes is attributable to U.S. federal, state, and foreign income taxes. The Company’s effective tax rate for the interim period ended June 30, 2024 is 20.12% and is based on an estimated annual effective tax rate including the tax effect of items required to be recorded discretely in the interim periods in which those items occur. A comparison of the Company’s effective tax rates for the three months ended June 30, 2024 and June 30, 2023 is not meaningful due to the amount of pre-tax income, and income tax expense recorded during the prior period.
The Company's effective tax rate is different than the statutory rates in the U.S. due to foreign income taxed at different rates than the U.S., changes in uncertain tax benefit positions, changes to valuation allowances, generation of tax credits, and the impact of Global Intangible Low Tax Income (GILTI) in the U.S. In addition, the Company has numerous tax holidays it receives related to its Thailand manufacturing operations based on its investment in property, plant and equipment in
Thailand. The Company's tax holiday periods in Thailand expire at various times in the future, however, the Company actively seeks to obtain new tax holidays. The material components of foreign income taxed at a rate lower than the U.S. are earnings accrued in Thailand, Malta, and Ireland.
The Company files U.S. federal, U.S. state, and foreign income tax returns. For U.S. federal, and in general for U.S. state tax returns, the fiscal 2007 and later tax years remain open for examination by tax authorities. For foreign tax returns, the Company is generally no longer subject to income tax examinations for years prior to fiscal 2007.
In September 2021, the Company received a Statutory Notice of Deficiency (2007 to 2012 Notice) from the United States Internal Revenue Service (IRS) for fiscal 2007 through fiscal 2012. The disputed amounts largely relate to transfer pricing matters. In December 2021, the Company filed a petition in the U.S. Tax Court challenging the 2007 to 2012 Notice.
In September 2023, the Company received a Revenue Agent Report (RAR) from the IRS for fiscal 2013 and fiscal 2016. In October 2023, the Company received a Statutory Notice of Deficiency (2014 to 2015 Notice) from the IRS for fiscal 2014 and fiscal 2015. The disputed amounts for fiscal 2013 to fiscal 2016 largely relate to transfer pricing matters. In December 2023, the Company filed a petition in the U.S. Tax Court challenging the 2014 to 2015 Notice.
In May 2023, the Company received a proposed income adjustment from the Malaysian Inland Revenue Board (IRB) for fiscal 2020. In December 2023, the Company received a Notice of Assessment from the IRB asserting the same proposed income adjustment. If the adjustment is upheld by the highest court that has jurisdiction over this matter in Malaysia, it could result in income taxes and penalties up to $410.0 million. The disputed amounts largely relate to the characterization of certain assets. Depending on the outcome of the IRB audit, the Company may need to adjudicate this matter in Malaysia, and if the Company does, the Company may be required to pay the assessment and then, upon a series of favorable court rulings, request a refund of the amount. The timing of adjudicating this matter is uncertain but could commence in the next 12 months.
The Company firmly believes that the assessments described above are without merit and plans to pursue all available administrative and judicial remedies necessary to resolve these matters. The Company intends to vigorously defend the positions and the Company is confident in its ability to prevail on the merits. The Company regularly assesses the likelihood of adverse outcomes resulting from examinations such as these to determine the adequacy of the Company's tax reserves. The ultimate outcome of disputes of this nature is uncertain, and if the IRS and IRB were to prevail on their assertions, the assessed tax, penalties, and deficiency interest could have a material adverse impact on the Company's financial position, results of operations or cash flows.
Note 12. Share-Based Compensation
The following table presents the details of the Company's share-based compensation expense (in millions):
| | | | | | | | | | | | | | | | | | | | | |
| | | Three Months Ended June 30, | | |
| | | | | | | 2024 | | 2023 | | | | |
Cost of sales(1) | | | | | | | $ | 6.6 | | | $ | 6.8 | | | | | |
Research and development | | | | | | | 23.3 | | | 22.9 | | | | | |
Selling, general and administrative | | | | | | | 14.1 | | | 14.8 | | | | | |
| | | | | | | | | | | | | |
Pre-tax effect of share-based compensation | | | | | | | 44.0 | | | 44.5 | | | | | |
Income tax benefit | | | | | | | 9.2 | | | 9.4 | | | | | |
Net income effect of share-based compensation | | | | | | | $ | 34.8 | | | $ | 35.1 | | | | | |
(1) During the three months ended June 30, 2024, $5.0 million of share-based compensation expense was capitalized to inventory and $6.6 million of previously capitalized share-based compensation expense in inventory was sold. During the three months ended June 30, 2023, $5.2 million of share-based compensation expense was capitalized to inventory and $6.8 million of previously capitalized share-based compensation expense in inventory was sold.
Note 13. Stock Repurchase Activity
In November 2021, the Company's Board of Directors approved a stock repurchase program to repurchase up to $4.00 billion of the Company's common stock in the open market or in privately negotiated transactions. There is no expiration date associated with the repurchase program. During the three months ended June 30, 2024, the Company purchased approximately 0.8 million shares of its common stock for a total cost of $72.7 million, including the 1% excise tax on stock repurchases enacted by the Inflation Reduction Act of 2022 (Inflation Reduction Act). As of June 30, 2024, approximately $1.57 billion remained available for repurchases under the program. Shares repurchased are recorded as treasury shares and are used to fund share issuance requirements under the Company's equity incentive plans. As of June 30, 2024, the Company had approximately 41.3 million treasury shares.
Note 14. Accumulated Other Comprehensive Loss
The following table presents the changes in the components of accumulated other comprehensive loss, net of tax (in millions):
| | | | | | | | | | | | | | | | | | | |
| | | Minimum Pension Liability | | Foreign Currency | | Total |
Balance at March 31, 2024 | | | $ | 11.6 | | | $ | (15.1) | | | $ | (3.5) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Net other comprehensive loss | | | (0.2) | | | — | | | (0.2) | |
| | | | | | | |
Balance at June 30, 2024 | | | $ | 11.4 | | | $ | (15.1) | | | $ | (3.7) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Note 15. Dividends
A quarterly cash dividend of $0.452 per share was paid on June 5, 2024 in the aggregate amount of $242.6 million. A quarterly cash dividend of $0.454 per share was declared on August 1, 2024 and will be paid on September 5, 2024 to stockholders of record as of August 22, 2024. The Company expects the September 2024 payment of its quarterly cash dividend to be approximately $243.8 million.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Note Regarding Forward-looking Statements
This report, including "Part I – Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Part II - Item 1A. Risk Factors" contains certain forward-looking statements that involve risks and uncertainties, including statements regarding our strategy, financial performance and revenue sources. We use words such as "anticipate," "believe," "can," "continue," "could," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Our actual results could differ materially from the results anticipated in these forward-looking statements as a result of certain factors including those set forth under "Risk Factors," beginning at page 36 and elsewhere in this Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements. We disclaim any obligation to update information contained in any forward-looking statement. These forward-looking statements include, without limitation, statements regarding the following: •The future impact on our business in response to public health concerns;
•Our expectation that we will experience period-to-period fluctuations in operating results, gross margins, product mix and average gross profit per unit;
•The effects that uncertain global economic conditions and fluctuations in the global credit and equity markets may have on our financial condition and results of operations;
•The effects and amount of competitive pricing pressure on our product lines and modest pricing declines in certain of our more mature proprietary product lines;
•Our ability to moderate future average selling price declines;
•The amount of, and changes in, demand for our products and those of our customers;
•The impact of national security protections, trade restrictions and changes in tariffs, including those impacting China;
•Our intent to vigorously defend our legal positions and our expectations of the impact of litigation on our operations;
•Our goal to continue to be more efficient with our selling, general and administrative expenses;
•Our belief that customers recognize our products and brand name and our use of distributors as an effective supply channel;
•Our belief that familiarity with and adoption of development tools from us and from our third-party development tool partners will be an important factor in the future selection of our embedded control products;
•The accuracy of our estimates of the useful life and values of our property, assets and other liabilities;
•The possibility of future pricing fluctuations in our analog product line;
•The impact of any supply disruption we may experience;
•Our ability to effectively utilize our facilities at appropriate capacity levels;
•Our ability to maintain manufacturing yields;
•The maintenance of our competitive position based on our investments in new and enhanced products;
•The cost effectiveness of using our own assembly and test operations;
•Our plans to continue to transition certain outsourced assembly and test capacity to our internal facilities;
•Our expectations regarding investments and the timeline of expansions of our manufacturing capacity;
•The continued development of the embedded control market based on our strong technical service presence;
•Our anticipated level of capital expenditures;
•The possibility that loss of, or disruption in the operations of, one or more of our distributors could reduce our future net sales and/or increase our inventory returns;
•Our intent, including length, timing, and planned shutdown days, to reduce production levels at global fabrication facilities and its impact on inventory levels;
•Our expectations regarding LTSAs, the Preferred Supply Program, and the realization of deferred revenue;
•The continuation and amount of quarterly cash dividends;
•The sufficiency of our existing sources of liquidity to finance anticipated capital expenditures and otherwise meet our anticipated cash requirements, and the effects that our contractual obligations are expected to have on them;
•Our belief that the capital expenditures to be incurred over the next 12 months will provide sufficient manufacturing capacity to support the growth of our production capabilities for our new products and technologies and to bring in-house more of the production requirements that are currently outsourced;
•Our belief that our IT system compromise has not had a material adverse effect on our business or resulted in any material damage to us;
•Our expectation that we will continue to be the target of cyber-attacks, computer viruses, unauthorized access and other attempts to breach or otherwise compromise the security of our IT systems and data;
•Our plans to modify and enhance our cybersecurity risk management processes and strategy;
•The impact of the resolution of legal actions on our business, and the accuracy of our assessment of the probability of loss and range of potential loss;
•The amounts and timing, and our plans and expectations relating to the U.S. Statutory Notice of Deficiencies and proposed income adjustment from the Malaysian Inland Revenue Board;
•Our expectation regarding the treatment of our unrecognized tax benefits in the next 12 months;
•Our belief that the expiration of any tax holidays will not have a material impact on our effective tax rate;
•Our expectations regarding our tax expense, cash taxes and effective tax rate;
•Our expectation that the global minimum tax (GMT) will not have a material impact on our fiscal 2025 results;
•Our belief that the estimates used in preparing our condensed consolidated financial statements are reasonable;
•Our actions to vigorously and aggressively defend and protect our intellectual property on a worldwide basis;
•Our ability to obtain and maintain patents and intellectual property licenses and minimize the effects of litigation or other disputes or the loss of patent protection;
•The level of risk we are exposed to for product liability claims or indemnification claims;
•The effect of fluctuations in market interest rates on our income and/or cash flows;
•The effect of fluctuations in currency rates;
•The impact of inflation on our business;
•Our ability to increase our borrowings or seek additional equity or debt financing to maintain or expand our facilities, or to fund cash dividends, share repurchases, acquisitions or other corporate activities, and that the timing and amount of such financing requirements will depend on a number of factors;
•Our expected debt obligation maturities and plans to refinance our existing debt;
•Our expectations regarding the amounts and timing of repurchases under our stock repurchase program;
•Our expectation that our reliance on third-party contractors may increase over time as our business grows;
•Our ability to collect accounts receivable;
•The impact of the legislative and policy changes implemented or which may be implemented by the current administration on our business and the trading price of our stock;
•Our belief that our culture, values, and organizational development and training programs will continue to provide an inclusive work environment where our employees are empowered and engaged to deliver the best embedded control solutions;
•Our belief that our continued success is driven by the skills, knowledge, and innovative capabilities of our personnel, a strong technical service presence, and our ability to rapidly commercialize new and enhanced products;
•The potential impact of changes in regulations or in their enforcement, including with respect to the capital expenditures or other costs or expenses;
•The impact of any failure by use to adequately control the storage, use, discharge and disposal of regulated substances;
•Estimates and plans regarding pension liability and payments expected to be made for benefits earned;
•Our expectations regarding the amount, timing, and future applications for investment tax credits under the CHIPS Act;
•Our expectations regarding past or potential future acquisitions, joint development agreements or other strategic relationships and any related benefits; and
•The impact on our business stemming from Russia’s invasion of Ukraine.
Our actual results could differ materially from the results anticipated in these forward-looking statements as a result of certain factors including those set forth in "Item 1A. Risk Factors," and elsewhere in this Form 10-Q. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements. We disclaim any obligation to update the information contained in any forward-looking statement.
Introduction
The following discussion should be read in conjunction with the condensed consolidated financial statements and the related notes that appear elsewhere in this document.
We begin our Management's Discussion and Analysis of Financial Condition and Results of Operations with a summary of business and macroeconomic developments followed by a summary of our overall business strategy to provide an overview of the goals and overall direction of our business. This is followed by a discussion of the Critical Accounting Policies and Estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results. We then discuss our Results of Operations for the three months ended June 30, 2024 compared to the three months ended June 30, 2023, followed by an analysis of changes in our balance sheet and cash flows, and discuss our financial commitments in the section titled "Liquidity and Capital Resources."
Business and Macroeconomic Environment
During fiscal 2024, many of our customers felt the adverse effects of slowing economic activity, increasing business uncertainty, persistent inflation and higher interest rates and we received requests to push out or cancel backlog resulting from customer actions to reduce inventory levels. Although we began to see evidence of improvements in our business in the March 2024 quarter which continued in the June 2024 quarter, such as a decrease in customer requests to push out or cancel backlog while bookings increased and the number of expedites and shipment pull in requests grew, overall the macroeconomic environment remained weak in the June 2024 quarter. With the exception of certain markets we serve including aerospace and defense, and the artificial intelligence subset of data centers our customers continued to reduce inventory levels, driven by business uncertainty, ample supply, and shorter product lead times. We continue to prioritize our efforts to manage our high inventory levels, and our global production facilities continue to run at lower utilization rates. Consistent with the weak macroeconomic environment, most of our factory expansion activity remains paused and we have reduced our planned capital investments through fiscal 2025. We are unable to predict the timing or impact of any such slowdown on our business.
Strategy
We develop, manufacture and sell smart, connected and secure embedded control solutions used by our customers for a wide variety of applications. Our strategic focus includes general purpose and specialized 8-bit, 16-bit, and 32-bit mixed-signal microcontrollers, microprocessors, analog, FPGA, and memory products. With over 30 years of technology leadership, our broad product portfolio is a Total System Solution (TSS) for our customers that can provide a large portion of the silicon requirements in their applications. TSS is a combination of hardware, software and services which help our customers increase their revenue, reduce their costs and manage their risks compared to other solutions. Our synergistic product portfolio empowers disruptive growth trends, including 5G, data centers, sustainability, Internet of Things (IoT) and edge computing, advanced driver assist systems (ADAS) and autonomous driving, and electric vehicles, in key end markets such as automotive, aerospace and defense, communications, consumer appliances, data centers and computing, and industrial.
Our manufacturing operations include wafer fabrication, wafer probe, assembly and test. In fiscal 2023, we announced our intent to expand our production capacity in the U.S. In the first three quarters of fiscal 2024, we continued our multi-year $800 million capacity expansion plan at Fab 4 in Gresham, Oregon and $880 million plan to expand our SiC and silicon production capacity, including the production of 8-inch wafers at Fab 5 in Colorado Springs, Colorado. In the fourth quarter of fiscal 2024, we paused our expansion efforts until business conditions warrant expansion. The ownership of a substantial portion of our manufacturing resources is an important component of our business strategy, enabling us to maintain a high level of manufacturing control, resulting in us being one of the lowest cost producers in the embedded control industry. By owning wafer fabrication facilities and our assembly and test operations, and by employing statistical techniques (statistical process control, designed experiments and wafer level monitoring), we have been able to achieve and maintain high production yields. Direct control over manufacturing resources allows us to shorten our design and production cycles. This control also allows us to capture a portion of the wafer manufacturing and assembly and testing profit margin. We outsource a significant portion of our manufacturing requirements to third parties and the amount of our outsourced manufacturing has increased in recent years due to our acquisitions of Microsemi and other companies that outsourced all or substantial portions of their manufacturing.
We employ proprietary design and manufacturing processes in developing our embedded control products. We believe our processes afford us both cost-effective designs in existing and derivative products and greater functionality in new product designs. While many of our competitors develop and optimize separate processes for their logic and memory product lines, we use a common process technology for both mixed-signal microcontroller and non-volatile memory
products. This allows us to more fully leverage our process research and development costs and to deliver new products to market more rapidly. Our engineers utilize advanced computer-aided design tools and software to perform circuit design, simulation and layout, and our in-house photomask and wafer fabrication facilities enable us to rapidly verify design techniques by processing test wafers quickly and efficiently.
We are committed to continuing our investment in new and enhanced products, including development systems, and in our design and manufacturing process technologies. We believe these investments are significant factors in maintaining our competitive position. Our current research and development activities focus on the design of new mixed-signal microcontrollers, digital signal controllers, memory, analog and mixed-signal products, FPGAs, timing systems, Flash-IP, development systems, software and application-specific software libraries. We are also developing new design and process technologies to achieve further cost reductions and performance improvements in our products.
We market and sell our products worldwide primarily through a network of direct sales personnel and distributors. Our direct sales force focuses on a wide variety of strategic accounts in three geographical markets: the Americas, Europe and Asia. We currently maintain sales and technical support centers in major metropolitan areas in all three geographic markets. We believe that a strong technical service presence is essential to the continued development of the embedded control market. Many of our CEMs, ESEs, and sales managers have technical degrees or backgrounds and have been previously employed in high technology environments. We believe that the technical and business knowledge of our sales force is a key competitive advantage in the sale of our products. The primary mission of our ESE team is to provide technical assistance to customers and to conduct periodic training sessions for our sales team. ESEs also frequently conduct technical seminars and workshops in major cities around the world or through online webcasts. Our licensing division has dedicated sales, technology, design, product, test and reliability personnel that support the requirements of our licensees.
See the risk factor captioned "Our operating results are impacted by seasonality and wide fluctuations of supply and demand in the industry" on page 43 for discussion of the impact of seasonality on our business.
Critical Accounting Policies and Estimates
There were no changes to our critical accounting policies and estimates during the first three months of the fiscal year ending March 31, 2025 compared to our "Critical Accounting Policies and Estimates" as previously described in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
Results of Operations
The following table sets forth certain operational data as a percentage of net sales for the periods covered by this report:
| | | | | | | | | | | | | | | | | | | | | |
| | | | | Three Months Ended June 30, |
| | | | | | | | | | | 2024 | | 2023 |
Net sales | | | | | | | | | | | 100.0 | % | | 100.0 | % |
Cost of sales | | | | | | | | | | | 40.6 | | | 31.9 | |
Gross profit | | | | | | | | | | | 59.4 | | | 68.1 | |
| | | | | | | | | | | | | |
Research and development | | | | | | | | | | | 19.5 | | | 13.0 | |
Selling, general and administrative | | | | | | | | | | | 12.1 | | | 8.9 | |
Amortization of acquired intangible assets | | | | | | | | | | | 9.9 | | | 6.6 | |
Special charges and other, net | | | | | | | | | | | 0.2 | | | 0.1 | |
Operating income | | | | | | | | | | | 17.7 | % | | |